IoM to Study Effectiveness of FDA's 510(k) Review Process for Medical Devices
September 30, 2009
IoM to Study Effectiveness of FDA's 510(k) Review Process for Medical Devices
Since the FDA has indicated that most IVDMIAs will have to undergo either 510(k) or premarket approval, the IoM's recommendations will certainly have implications for this subset of devices.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- FDA Seeks Public Views on Proposed 510(k) Plans
August 1, 2011 / GenomeWeb Daily News - IOM Report Urges FDA Shift from 510(k) Program
August 1, 2011 / GenomeWeb Daily News - Affymetrix Files for FDA Clearance of CytoScan HD
February 15, 2013 / GenomeWeb Daily News - Eyeing 2014 FDA Submission for Unyvero System, Curetis Starts Clinical Trial
December 6, 2012 / GenomeWeb Daily News - Seeking 510(k) Clearance for Genomic Testing Service, 23andMe Maintains Direct-to-Consumer Ethos
August 1, 2012 / Pharmacogenomics Reporter